Oral Therapeutics and Pharmacology最新文献

筛选
英文 中文
A pilot study of dental pharmacotherapy for alveolar bone regeneration 牙槽骨再生的牙科药物治疗的初步研究
Oral Therapeutics and Pharmacology Pub Date : 2017-01-01 DOI: 10.11263/JSOTP.17.13
M. Kawai, M. Kawai, Fumihiko Kohno, M. Sakumoto, Ayumi Taeda, N. Shiotsu, Toshio Yamamoto, K. Ohura
{"title":"A pilot study of dental pharmacotherapy for alveolar bone regeneration","authors":"M. Kawai, M. Kawai, Fumihiko Kohno, M. Sakumoto, Ayumi Taeda, N. Shiotsu, Toshio Yamamoto, K. Ohura","doi":"10.11263/JSOTP.17.13","DOIUrl":"https://doi.org/10.11263/JSOTP.17.13","url":null,"abstract":"","PeriodicalId":19590,"journal":{"name":"Oral Therapeutics and Pharmacology","volume":"36 1","pages":"101-107"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63802104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mucogingival surgery: where we stand today. 黏膜龈手术:我们的现状。
Oral Therapeutics and Pharmacology Pub Date : 2011-08-01 DOI: 10.1080/19424396.2011.12221930
Vivek K Bains, Vivek Gupta, G P Singh, Rhythm Bains
{"title":"Mucogingival surgery: where we stand today.","authors":"Vivek K Bains, Vivek Gupta, G P Singh, Rhythm Bains","doi":"10.1080/19424396.2011.12221930","DOIUrl":"10.1080/19424396.2011.12221930","url":null,"abstract":"<p><p>Mucogingival problems are developmental and acquired aberrations in the morphology, position, and/or the amount of gingiva surrounding teeth. According to an academic report by American Academy of Periodontology, mucogingival therapy should be advocated for gingival augmentation and to create adequate vestibular depth in areas with insufficient attached gingiva. This paper provides an overview on mucogingival surgical procedures from its inception to the current time.</p>","PeriodicalId":19590,"journal":{"name":"Oral Therapeutics and Pharmacology","volume":"1 1","pages":"573-83"},"PeriodicalIF":0.0,"publicationDate":"2011-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85859789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Triacylated lipopeptide, a component of Gram-positive bacteria, induces osteoclastogenesis in the absence of RANKL and resorbs calvarial bone in vivo through Toll-like receptor 2 三酰化脂肽是革兰氏阳性菌的一种成分,在缺乏RANKL的情况下诱导破骨细胞发生,并通过toll样受体2在体内吸收颅骨骨
Oral Therapeutics and Pharmacology Pub Date : 2010-04-01 DOI: 10.11263/JSOTP.29.9
Keiko Suzuki, S. Yamada
{"title":"Triacylated lipopeptide, a component of Gram-positive bacteria, induces osteoclastogenesis in the absence of RANKL and resorbs calvarial bone in vivo through Toll-like receptor 2","authors":"Keiko Suzuki, S. Yamada","doi":"10.11263/JSOTP.29.9","DOIUrl":"https://doi.org/10.11263/JSOTP.29.9","url":null,"abstract":"","PeriodicalId":19590,"journal":{"name":"Oral Therapeutics and Pharmacology","volume":"29 1","pages":"9-14"},"PeriodicalIF":0.0,"publicationDate":"2010-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63802411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Analysis of the stability and microbiological safety of aznol saline gargle in hospital preparations widely used for the treatment of oral cancer patients with oral mucositis 广泛用于治疗口腔癌合并口腔黏膜炎患者的医院制剂中氮盐含漱液的稳定性和微生物安全性分析
Oral Therapeutics and Pharmacology Pub Date : 2008-12-01 DOI: 10.11263/JSOTP1982.27.143
M. Ushiyama, R. Ikeda, T. Nitta, Yusuke Tazitsu, A. Miyawaki, Tatsuya Yamaguchi, Y. Shimodouzono, K. Ushinohama, R. Matsui, K. Sugihara, N. Nakamura, Katsushi Yamada
{"title":"Analysis of the stability and microbiological safety of aznol saline gargle in hospital preparations widely used for the treatment of oral cancer patients with oral mucositis","authors":"M. Ushiyama, R. Ikeda, T. Nitta, Yusuke Tazitsu, A. Miyawaki, Tatsuya Yamaguchi, Y. Shimodouzono, K. Ushinohama, R. Matsui, K. Sugihara, N. Nakamura, Katsushi Yamada","doi":"10.11263/JSOTP1982.27.143","DOIUrl":"https://doi.org/10.11263/JSOTP1982.27.143","url":null,"abstract":"","PeriodicalId":19590,"journal":{"name":"Oral Therapeutics and Pharmacology","volume":"27 1","pages":"143-150"},"PeriodicalIF":0.0,"publicationDate":"2008-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63820598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Results of medicine revaluation in the odontology department 齿科药物重估结果分析
Oral Therapeutics and Pharmacology Pub Date : 2008-12-01 DOI: 10.11263/JSOTP1982.27.151
Yoshio Saito
{"title":"Results of medicine revaluation in the odontology department","authors":"Yoshio Saito","doi":"10.11263/JSOTP1982.27.151","DOIUrl":"https://doi.org/10.11263/JSOTP1982.27.151","url":null,"abstract":"","PeriodicalId":19590,"journal":{"name":"Oral Therapeutics and Pharmacology","volume":"27 1","pages":"151-156"},"PeriodicalIF":0.0,"publicationDate":"2008-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63820157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A possible therapeutic for gingival overgrowth caused by calcium channel blockers 一种治疗钙通道阻滞剂引起的牙龈过度生长的可能方法
Oral Therapeutics and Pharmacology Pub Date : 2008-08-01 DOI: 10.11263/JSOTP1982.27.103
H. Matsumoto, R. Takeuchi, M. Ono, Y. Akimoto, A. Fujii
{"title":"A possible therapeutic for gingival overgrowth caused by calcium channel blockers","authors":"H. Matsumoto, R. Takeuchi, M. Ono, Y. Akimoto, A. Fujii","doi":"10.11263/JSOTP1982.27.103","DOIUrl":"https://doi.org/10.11263/JSOTP1982.27.103","url":null,"abstract":"In the present study, the results of characters in nifedipine responders (NIFr) and nifedipine non-responders (NIFn) are summarized, and the possibility of using tenidap and 18ƒ¿ -glycyrrhetinic acid (18ƒ¿-GA) as a therapeutic for gingival overgrowth caused by calcium channel blockers is investigated. 18ƒ¿-GA inhibited cell proliferation and G1/S transition were induced in NIFr cells. It was also shown that cell cycle control proteins were down-stream targets in the growth-inhibition activity of 18ƒ¿-GA in NIFr cells. Tenidap discharges intracellular Ca2+ store, resulting in a depletion of intracellular Ca2+ store in NIFr cells. It also inhibits cell growth, DNA and collagen syntheses, lowered intracellular pH, and enhanced matrix metalloproteinase-1 formation in NIFr cells. These results suggest that 18ƒ¿-GA and tenidap might be effective for the prevention of gingival overgrowth caused by calcium channel blockers.","PeriodicalId":19590,"journal":{"name":"Oral Therapeutics and Pharmacology","volume":"27 1","pages":"103-108"},"PeriodicalIF":0.0,"publicationDate":"2008-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63820353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A randomized controlled trial comparison between ropivacaine and 2% lidocaine containing adrenalin for inferior alveolar nerve block during implant surgery 一项随机对照试验比较罗哌卡因和2%利多卡因含肾上腺素在种植手术中用于下牙槽神经阻滞
Oral Therapeutics and Pharmacology Pub Date : 2008-08-01 DOI: 10.11263/JSOTP1982.27.125
S. Ogura, K. Shinohara, Katsuhisa Sunada, H. Takamori, Kiminari Nakamura
{"title":"A randomized controlled trial comparison between ropivacaine and 2% lidocaine containing adrenalin for inferior alveolar nerve block during implant surgery","authors":"S. Ogura, K. Shinohara, Katsuhisa Sunada, H. Takamori, Kiminari Nakamura","doi":"10.11263/JSOTP1982.27.125","DOIUrl":"https://doi.org/10.11263/JSOTP1982.27.125","url":null,"abstract":"","PeriodicalId":19590,"journal":{"name":"Oral Therapeutics and Pharmacology","volume":"27 1","pages":"125-130"},"PeriodicalIF":0.0,"publicationDate":"2008-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.11263/JSOTP1982.27.125","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63820487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Study on the mechanism of collagen metabolism in phenytoin-induced gingival overgrowth 苯妥英诱导牙龈过度生长中胶原代谢机制的研究
Oral Therapeutics and Pharmacology Pub Date : 2008-08-01 DOI: 10.11263/JSOTP1982.27.86
Takahiro Kato
{"title":"Study on the mechanism of collagen metabolism in phenytoin-induced gingival overgrowth","authors":"Takahiro Kato","doi":"10.11263/JSOTP1982.27.86","DOIUrl":"https://doi.org/10.11263/JSOTP1982.27.86","url":null,"abstract":"Gingival overgrowth is a serious adverse effect associated with the administration of phenytoin (PHT), with PHT-induced gingival overgrowth characterized by a massive accumulation of extracellular matrix components, especially collagen, in gingival connective tissues. However, the etiology of such collagen accumulation is still largely unknown. We examined the effects of PHT on the collagen degradation process leading to collagen accumulation in human gingival fibroblasts (HGF). PHT causes an impaired degradation of collagen by suppression of enzymatic degradation with MMPs/TIMP-1 and ƒ¿2 ƒÀ1 integrin mediated endocytosis. These synergistic effects may cause collagen accumulation, leading to gingival overgrowth. It has also been reported that dental plaque is the most important factor to enhance deterioration caused by PHT-induced","PeriodicalId":19590,"journal":{"name":"Oral Therapeutics and Pharmacology","volume":"27 1","pages":"86-91"},"PeriodicalIF":0.0,"publicationDate":"2008-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63820638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current status of treatment modalities for drug-induced gingival overgrowth 药物性牙龈过度生长的治疗现状
Oral Therapeutics and Pharmacology Pub Date : 2008-08-01 DOI: 10.11263/JSOTP1982.27.68
Koichi Ito
{"title":"Current status of treatment modalities for drug-induced gingival overgrowth","authors":"Koichi Ito","doi":"10.11263/JSOTP1982.27.68","DOIUrl":"https://doi.org/10.11263/JSOTP1982.27.68","url":null,"abstract":"Gingival hyperplasia (overgrowth) is a well-documented unwanted effect, associated with phenytoin, the calcium channel blockers, and cyclosporin. The pathogenesis of drug-induced gingival hyperplasia is uncertain. However, the identification of risk factors associated with both the prevalence and severity of drug-induced gingival hyperplasia is important for all parties involved with this unwanted effect. Prevalence of gingival hyperplasia with phenytoin, the calcium channel blockers, and cyclosporin is approximately 50%, 10-20%, and 8-70%, respectively. The inflammatory components of drug-induced gingival hyperplasia can be managed effectively for the majority of patients with a plaque control program and nonsurgical periodontal therapy including oral hygiene instruction, scaling and root planing coupled with continued periodontal maintenance procedures. After reevaluation, some patients may need surgical periodontal therapy and maintenance procedures. Maintenance therapy including appropriate oral home care appear to be effective in controlling the drug-induced gingival hyperplasia and in maintaining clinical improvements for a long time.","PeriodicalId":19590,"journal":{"name":"Oral Therapeutics and Pharmacology","volume":"27 1","pages":"68-78"},"PeriodicalIF":0.0,"publicationDate":"2008-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63820777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medical lawsuits judged by using drug package inserts as criteria for the judicial decisions 以药品说明书为裁判标准的医疗诉讼
Oral Therapeutics and Pharmacology Pub Date : 2008-08-01 DOI: 10.11263/JSOTP1982.27.116
Yohko Kaku, K. Enami, M. Fukumoto, M. Yamaguchi, K. Shibutani
{"title":"Medical lawsuits judged by using drug package inserts as criteria for the judicial decisions","authors":"Yohko Kaku, K. Enami, M. Fukumoto, M. Yamaguchi, K. Shibutani","doi":"10.11263/JSOTP1982.27.116","DOIUrl":"https://doi.org/10.11263/JSOTP1982.27.116","url":null,"abstract":"","PeriodicalId":19590,"journal":{"name":"Oral Therapeutics and Pharmacology","volume":"27 1","pages":"116-124"},"PeriodicalIF":0.0,"publicationDate":"2008-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63820433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信